Table 2.
All Patients | MAC | NMAC | p-Values 1 | |
---|---|---|---|---|
n = 433 (%) | n = 54 (%) | n = 379 (%) | ||
Sex | 0.785 | |||
Male | 266 | 30 (56) | 248 (58) | |
Female | 185 | 24 (44) | 161 (42) | |
Age (years) | 0.267 | |||
≤69 | 202 | 29 (54) | 173 (46) | |
>69 | 231 | 25 (46) | 206 (54) | |
TNM stage | 0.015 | |||
I | 129 | 7 (13) | 122 (32) | |
IIA | 110 | 10 (19) | 100 (26) | |
IIB | 10 | 2 (4) | 8 (2) | |
IIIA | 17 | 2 (4) | 15 (4) | |
IIIB | 57 | 11 (20) | 46 (12) | |
IIIC | 56 | 11 (20) | 45 (12) | |
IV | 54 | 11 (20) | 43 (11) | |
T-stage | 0.008 | |||
T1 | 49 | 0 | 49 (13) | |
T2 | 113 | 11 (20) | 102 (27) | |
T3 | 230 | 35 (65) | 195 (52) | |
T4 | 38 | 8 (15) | 30 (8) | |
Unknown | 3 | 0 | 3 (1) | |
N-stage | 0.013 | |||
N0 | 244 | 21 (41) | 223 (63) | |
N1 | 86 | 15 (29) | 71 (20) | |
N2 | 77 | 15 (29) | 62 (17) | |
Unknown | 26 | 3 (6) | 23 (6) | |
Vascular invasion | 0.676 | |||
Yes | 87 | 12 (22) | 75 (20) | |
No | 346 | 42 (78) | 304 (80) | |
Perineural growth | 0.340 | |||
Yes | 58 | 5 (9) | 53 (14) | |
No | 375 | 49 (91) | 326 (86) | |
Differentiation | <0.001 | |||
Well | 42 | 1 (2) | 41 (11) | |
Moderately | 287 | 19 (35) | 251 (66) | |
Poorly | 132 | 34 (63) | 87 (23) |
MAC = mucinous adenocarcinoma, NMAC = non-mucinous adenocarcinoma. 1 p-values calculated by Chi-square test and compare MAC patients and NMAC patients.